Literature DB >> 44712

Sensitive gas chromatographic method for the determination in blood and urine of SL 75212 [4-(2-cyclopropylmethoxyethyl)-1-phenoxy-3-isopropylaminopropan-2-ol], a new beta 1 adrenoceptor blocking agent.

G Bianchetti, J Ganansia, P L Morselli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 44712     DOI： 10.1016/s0021-9673(00)92096-x

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  8 in total

1.  The effects of time and dose on the relative beta 1- and beta 2-adrenoceptor antagonism of betaxolol and atenolol.

Authors:  B J Lipworth; N A Irvine; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

2.  Betaxolol and glucose-insulin relationships: studies in normal subjects taking glibenclamide or metformin.

Authors:  A J Sinclair; I B Davies; S J Warrington
Journal:  Br J Clin Pharmacol       Date:  1990-11       Impact factor: 4.335

3.  Observation on the efficacy and pharmacokinetics of betaxolol (SL 75212), a cardioselective beta-adrenoceptor blocking drug.

Authors:  K Balnave; J D Neill; C J Russell; D W Harron; W J Leahey; R Wilson; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1981-02       Impact factor: 4.335

4.  Influence of environmental temperature and humidity on bronchial responses during assessment of selectivity of beta-adrenoceptor antagonists in man.

Authors:  E A Taylor; P W Trembath; S J Warrington
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

5.  A dose-ranging study to evaluate the beta-adrenoceptor selectivity of single doses of betaxolol.

Authors:  N A Irvine; B J Lipworth; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

6.  Beta-adrenoceptor blocking effects and pharmacokinetics of betaxolol (SL 75212) in man.

Authors:  J F Giudicelli; M Chauvin; C Thuillez; C Richer; G Bianchetti; R Gomeni; P L Morselli
Journal:  Br J Clin Pharmacol       Date:  1980-07       Impact factor: 4.335

7.  Blood concentrations and pharmacodynamic effects of betaxolol (SL 75212) a new beta-adrenoceptor antagonist after oral and intravenous administration.

Authors:  S J Warrington; P Turner; J R Kilborn; G Bianchetti; P L Morselli
Journal:  Br J Clin Pharmacol       Date:  1980-11       Impact factor: 4.335

8.  Cardiovascular effects of single oral doses of the new beta-adrenoceptor blocking agents betaxolol (SL 75212) in healthy volunteers.

Authors:  P J Cadigan; D R London; B L Pentecost; G Bianchetti; R Gomeni; J R Kilborn; P L Morselli
Journal:  Br J Clin Pharmacol       Date:  1980-06       Impact factor: 4.335
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.